These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3300684)

  • 1. Fluorescence flow cytometry and immunology applied to cancer.
    Wunderlich J
    Anal Quant Cytol Histol; 1987 May; 9(2):133-7. PubMed ID: 3300684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of monoclonal antibodies for purging autologous bone marrow in the lymphoid malignancies.
    Macintyre EA
    Clin Haematol; 1986 Feb; 15(1):249-67. PubMed ID: 3516492
    [No Abstract]   [Full Text] [Related]  

  • 3. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and classification of hematologic tumors using anti-lymphocyte monoclonal antibodies].
    Kikuchi K
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):551-8. PubMed ID: 6603817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular differentiation markers in lymphoproliferative diseases.
    Siegal FP
    Hosp Pract; 1978 Oct; 13(10):79-89. PubMed ID: 310413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of flow cytometry in the diagnosis of lymphoma: a critical analysis.
    Morse EE; Yamase HT; Greenberg BR; Sporn J; Harshaw SA; Kiraly TR; Ziemba RA; Fallon MA
    Ann Clin Lab Sci; 1994; 24(1):6-11. PubMed ID: 8147568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Membrane markers of lymphoid cells in immunoproliferative diseases of man].
    Seligmann M; Brouet JC; Preud'homme JL
    Z Gesamte Inn Med; 1980 Jan; 35(2):66-9. PubMed ID: 6996351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of monoclonal antibodies in the study of the lymphoid system. II. Classification and treatment of the leukemias].
    Blanco Quirós A; Alvarez Guisasola J
    An Esp Pediatr; 1982 Jul; 17(1):48-59. PubMed ID: 6982643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic and cytochemical characterization of lymphoreticular malignancies.
    Grogan TM; Hicks MJ; Jolley C
    Ariz Med; 1981 Jul; 38(7):524-8. PubMed ID: 6168251
    [No Abstract]   [Full Text] [Related]  

  • 10. Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes.
    Wang CY; Azzo W; Al-Katib A; Chiorazzi N; Knowles DM
    J Immunol; 1984 Aug; 133(2):684-91. PubMed ID: 6429242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unique human B lymphocyte antigen defined by a monoclonal antibody.
    Meeker TC; Miller RA; Link MP; Bindl J; Warnke R; Levy R
    Hybridoma; 1984; 3(4):305-20. PubMed ID: 6441771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
    Epstein AL; Marder RJ; Winter JN; Fox RI
    J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemical classification of cutaneous lymphomas and pseudolymphomas].
    Smolle J; Kaudewitz P; Aberer E; Torne R; Burg G; Kerl H
    Hautarzt; 1987 Aug; 38(8):461-6. PubMed ID: 3308776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.
    Theyer G; Kramer G; Assmann I; Sherwood E; Preinfalk W; Marberger M; Zechner O; Steiner GE
    Lab Invest; 1992 Jan; 66(1):96-107. PubMed ID: 1370561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic markers for classification of leukemias and non-Hodgkin lymphomas.
    Thierfelder S; Rodt H; Thiel E; Hoffmann-Fezer G; Netzel B; Haas RJ; Wündisch GF; Bender-Götze C
    Recent Results Cancer Res; 1979; 69():41-8. PubMed ID: 382307
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-T antibody reactivity in T and B cell lymphomas.
    Barcos M; Ozer H; Henderson E; Minowada J
    Prog Clin Biol Res; 1983; 133():183-9. PubMed ID: 6604921
    [No Abstract]   [Full Text] [Related]  

  • 17. Automatic lineage assignment of acute leukemias by flow cytometry.
    Verwer BJ; Terstappen LW
    Cytometry; 1993 Nov; 14(8):862-75. PubMed ID: 7507022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-grade lymphomas. Expression of developmentally regulated B-cell antigens.
    Cossman J; Neckers LM; Hsu S; Longo D; Jaffe ES
    Am J Pathol; 1984 Apr; 115(1):117-24. PubMed ID: 6201073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies to canine cell surface antigens: a comparison of screening assays.
    Ladiges WC; Durkopp N; Urban C; Wulff JC; Storb R
    Hybridoma; 1984; 3(4):387-90. PubMed ID: 6396199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.